Study design of a phase ii clinical trial to assess the efficacy and safety of eperisone in japanese type 2 diabetes patients with risk and non-risk alleles of CDKAL1

Kourin Sakakida, Fan Yan Wei, Takafumi Senokuchi, Seiya Shimoda, Tatsuyuki Kakuma, Eiichi Araki, Kazuhito Tomizawa

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Study design of a phase ii clinical trial to assess the efficacy and safety of eperisone in japanese type 2 diabetes patients with risk and non-risk alleles of CDKAL1'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds